Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate the effect of ARB in improving insulin secretion in
patients with type 2 diabetes. The investigators also aimed to evaluate if there are
potential synergisms between ARB and DPP4 inhibitors in improving insulin secretion and
urinary albumin secretion in diabetic patients.